EVE — EvoNext Holdings SA Share News
0.000.00%
Last trade - 00:00- CH₣12.87m
- CH₣6.97m
Brief: Evolva Holding collaborates with US Navy
Brief: Evolva Holding establishes sales office in Singapore
Brief: Evolva Holding announces teaming up with Cornelius Group
Brief: Evolva Holding: Evolva's nootkatone enters NIH-sponsored studies
Brief: Evolva Holding: resveratrol part of novel combination therapy to be tested
Brief: Evolva: Cargill EverSweet gets No Objection Letter from FDA
Brief: Evolva Holding granted patent number 2742142
Swiss stocks - Factors to watch on May 19
Brief: Evolva Holding says Angela Tsetsis to join Evolva Commercial Team
Brief: Evolva Holding sponsors study to assess impact of resveratrol supplementation
Brief: Evolva holding proposes Gerard Hoetmer as new Board member
develop next-generation materials with US Navy
Swiss stocks - Factors to watch on April 5
Brief: Evolva gains exclusive license from CDC to develop and commercialise nootkatone
Brief: Evolva Holding FY revenues up 25 pct to CHF 13.4 million
Swiss stocks - Factors to watch on March 24
Brief: Evolva Holding expands nootkatone research with CDC to include mosquitoes that transmit Zika
Swiss stocks - Factors to watch on March 2
Brief: Evolva Holding achieves milestones in alliance with Takasago